No Clinically Significant Interaction Between Sumatriptan and Augmentin
Sumatriptan and Augmentin (amoxicillin/clavulanate) can be safely co-administered without dose adjustment or special monitoring, as there is no documented pharmacokinetic or pharmacodynamic interaction between these medications.
Evidence Supporting Safe Co-Administration
Sumatriptan Metabolism and Drug Interactions
Sumatriptan is primarily metabolized by monoamine oxidase-A (MAO-A), not by cytochrome P450 enzymes 1. This metabolic pathway is critical because:
- Amoxicillin/clavulanate does not inhibit or induce MAO-A 2
- The primary route of sumatriptan elimination is renal excretion (60%) as inactive metabolites, with 40% fecal elimination 1
- Only 3% of sumatriptan is excreted unchanged in urine 1
Macrolide Antibiotic Studies Demonstrate CYP3A4 Independence
A definitive pharmacokinetic study evaluated sumatriptan co-administration with clarithromycin, a potent CYP3A4 inhibitor and macrolide antibiotic 3. This study found:
- Mean sumatriptan AUC increased only 9% with clarithromycin co-administration 3
- Cmax increased only 14% 3
- These minimal changes are not clinically significant and required no dose adjustment 3
This is particularly relevant because clarithromycin is a much more potent enzyme inhibitor than amoxicillin/clavulanate, which has no significant CYP450 inhibitory effects 2.
Augmentin's Limited Drug Interaction Profile
The FDA label for Augmentin identifies specific drug interactions, none of which involve triptans 2:
- Probenecid: Decreases renal tubular secretion of amoxicillin 2
- Oral anticoagulants: May prolong prothrombin time 2
- Allopurinol: Increases incidence of rashes with ampicillin-class antibiotics 2
- Oral contraceptives: May have reduced efficacy 2
Notably absent from this list are any serotonergic medications or migraine-specific agents 2.
Documented Sumatriptan Interactions to Avoid
While sumatriptan and Augmentin are safe together, clinicians should be aware of actual contraindicated combinations 4:
Absolute Contraindications (Within 24 Hours)
- Ergot alkaloids: Ergotamine, dihydroergotamine, methysergide 4
- Other triptans: Risk of additive vasoconstrictive effects 1
- MAO-A inhibitors: Can increase sumatriptan levels 7-fold with oral administration 1
Caution Required
- SSRIs/SNRIs: Theoretical risk of serotonin syndrome, though clinical evidence suggests most patients tolerate this combination 5
- Cardiovascular medications: Beta-blockers, antihypertensives when used with ergots (not relevant to sumatriptan alone) 4
Clinical Recommendations
Prescribe both medications without modification when treating a patient with migraine who requires antibiotic therapy for bacterial infection 6, 2:
- Continue sumatriptan at standard dosing (25-100 mg orally, maximum 200 mg/24 hours) 4, 1
- Administer Augmentin at appropriate doses for the infection being treated 2
- No additional monitoring beyond standard care for each medication is required 3
- Counsel patients to take Augmentin with food to reduce gastrointestinal upset 2
- Advise patients to begin migraine treatment as soon as possible after headache onset for optimal efficacy 6
Important Caveat
The absence of interaction does not mean both medications are always appropriate. Consider:
- Medication overuse headache: Limit triptan use to <10 days per month 6
- Antibiotic stewardship: Ensure bacterial infection is documented or strongly suspected before prescribing Augmentin 2
- Individual contraindications to each medication must still be respected (e.g., cardiovascular disease for sumatriptan, penicillin allergy for Augmentin) 4, 1, 2